GRYSKA DAVID W
Insider CIK 1202335 · SGEN Director · AERI Director · GWPH Director · HPTX Director · FBRX Director · CELC Director · MNMD Director · INCY Executive Vice President, CFO · PDLI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CELC Celcuity Inc. | A Award | 2026-10-01 | 2026-10-05 | 893 | — | $0 | 893 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 31,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 18,353 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 1,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | U Tender | 2026-08-27 | 2026-08-27 | 5,940 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 18,353 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 31,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 1,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | U Tender | 2026-08-27 | 2026-08-27 | 5,940 | — | — | 0 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award deriv | 2026-06-11 | 2026-06-15 | 19,188 | — | $0 | 19,188 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-06-11 | 2026-06-15 | 4,666 | — | $0 | 19,900 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 18,353 | — | $0 | 18,353 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2025-06-12 | 2025-06-16 | 75,187 | — | $0 | 75,187 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2025-03-20 | 2025-03-21 | 31,000 | — | $0 | 31,000 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | P Buy | 2024-12-05 | 2024-12-05 | 2,500 | $7.17 | $17.9K | 19,851 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | P Buy | 2024-08-23 | 2024-08-26 | 3,500 | $5.98 | $20.9K | 17,351 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2024-08-20 | 2024-08-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2024-06-10 | 2024-06-12 | 16,506 | — | $0 | 16,506 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,676 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,462 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 3,171 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 7,038 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 2,044 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 8,750 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer deriv | 2023-12-14 | 2023-12-15 | 9,260 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | D To issuer | 2023-12-14 | 2023-12-15 | 49,003 | $229.00 | $11.22M | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2023-09-19 | 2023-09-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award | 2023-07-31 | 2023-08-02 | 148,514 | $1.01 | $150.0K | 148,514 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2023-06-21 | 2023-06-23 | 13,131 | — | $0 | 13,131 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2023-06-21 | 2023-06-23 | 37,594 | — | $0 | 37,594 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award | 2023-06-21 | 2023-06-23 | 13,851 | — | $0 | 13,851 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2023-05-31 | 2023-06-02 | 2,044 | — | $0 | 51,047 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2023-02-13 | 2023-02-15 | 8,750 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2023-02-13 | 2023-02-15 | 8,750 | $36.70 | $321.1K | 49,003 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2023-01-10 | 2023-01-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | D To issuer deriv | 2022-11-21 | 2022-11-21 | 7,800 | $1.98 | $15.4K | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | D To issuer deriv | 2022-11-21 | 2022-11-21 | 16,854 | $9.14 | $154.0K | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | D To issuer | 2022-11-21 | 2022-11-21 | 1,996 | $15.25 | $30.4K | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | D To issuer | 2022-11-21 | 2022-11-21 | 11,495 | $15.25 | $175.3K | 0 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-11-11 | 2022-11-15 | 7,500 | $129.10 | $968.3K | 40,253 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2022-06-09 | 2022-06-13 | 16,854 | — | $0 | 16,854 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award | 2022-06-09 | 2022-06-13 | 6,245 | — | $0 | 11,495 | SEC↗ |
| SGEN Seagen Inc. | A Award deriv | 2022-05-13 | 2022-05-17 | 3,676 | — | $0 | 3,676 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2022-05-13 | 2022-05-17 | 1,503 | — | $0 | 47,753 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-04-19 | 2022-04-21 | 1,516 | — | $0 | 690 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-04-19 | 2022-04-21 | 1,794 | — | $0 | 2,206 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-04-19 | 2022-04-21 | 690 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-04-19 | 2022-04-21 | 1,794 | $20.06 | $36.0K | 48,044 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-04-19 | 2022-04-21 | 1,794 | $143.32 | $257.1K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-04-19 | 2022-04-21 | 1,516 | $20.06 | $30.4K | 47,766 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-04-19 | 2022-04-21 | 690 | $145.08 | $100.1K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-04-19 | 2022-04-21 | 690 | $20.06 | $13.8K | 46,940 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-04-19 | 2022-04-21 | 1,516 | $144.17 | $218.6K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-02-07 | 2022-02-09 | 2,371 | — | $0 | 4,000 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-02-07 | 2022-02-09 | 1,029 | — | $0 | 6,371 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-02-07 | 2022-02-09 | 1,100 | — | $0 | 7,400 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-02-07 | 2022-02-09 | 1,100 | $20.06 | $22.1K | 47,350 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-02-07 | 2022-02-09 | 2,371 | $139.42 | $330.6K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-02-07 | 2022-02-09 | 1,100 | $137.45 | $151.2K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-02-07 | 2022-02-09 | 1,029 | $20.06 | $20.6K | 47,279 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-02-07 | 2022-02-09 | 1,029 | $138.66 | $142.7K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-02-07 | 2022-02-09 | 2,371 | $20.06 | $47.6K | 48,621 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-01-28 | 2022-02-01 | 214 | — | $0 | 8,500 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-01-28 | 2022-02-01 | 883 | — | $0 | 8,714 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-01-28 | 2022-02-01 | 2,553 | — | $0 | 9,597 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-01-28 | 2022-02-01 | 850 | — | $0 | 12,150 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-01-28 | 2022-02-01 | 214 | $20.06 | $4.3K | 46,464 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-01-28 | 2022-02-01 | 214 | $124.23 | $26.6K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-01-28 | 2022-02-01 | 850 | $20.06 | $17.1K | 47,100 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-01-28 | 2022-02-01 | 883 | $123.39 | $109.0K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-01-28 | 2022-02-01 | 883 | $20.06 | $17.7K | 47,133 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-01-28 | 2022-02-01 | 2,553 | $122.43 | $312.6K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-01-28 | 2022-02-01 | 2,553 | $20.06 | $51.2K | 48,803 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-01-28 | 2022-02-01 | 850 | $121.69 | $103.4K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2022-01-14 | 2022-01-19 | 4,500 | — | $0 | 13,000 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2022-01-14 | 2022-01-19 | 4,500 | $135.24 | $608.6K | 46,250 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2022-01-14 | 2022-01-19 | 4,500 | $20.06 | $90.3K | 50,750 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2021-06-17 | 2021-06-21 | 7,800 | — | $0 | 7,800 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award | 2021-06-17 | 2021-06-21 | 1,750 | — | $0 | 5,250 | SEC↗ |
| SGEN Seagen Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 3,462 | — | $0 | 3,462 | SEC↗ |
| SGEN Seagen Inc. | A Award | 2021-05-14 | 2021-05-18 | 1,402 | — | $0 | 46,250 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 22,464 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 35,208 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-02-22 | 2021-02-24 | 22,464 | — | $0 | 22,464 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | S Sale | 2020-12-30 | 2020-12-31 | 20,000 | $2.74 | $54.8K | 1,387 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | S Sale | 2020-12-16 | 2020-12-17 | 75,000 | $2.68 | $201.0K | 21,387 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | M Exercise deriv | 2020-12-05 | 2020-12-09 | 66,050 | $1.64 | $108.3K | 0 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | M Exercise | 2020-12-05 | 2020-12-09 | 66,050 | $1.64 | $108.3K | 96,387 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | S Sale | 2020-12-03 | 2020-12-04 | 75,000 | $2.52 | $189.0K | 30,337 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | S Sale | 2020-11-23 | 2020-11-24 | 50,000 | $2.43 | $121.5K | 105,337 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2020-11-19 | 2020-11-23 | 7,871 | — | $0 | 0 | SEC↗ |
| SGEN Seagen Inc. | M Exercise deriv | 2020-11-19 | 2020-11-23 | 7,129 | — | $0 | 7,871 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2020-11-19 | 2020-11-23 | 7,129 | $19.02 | $135.6K | 51,977 | SEC↗ |
| SGEN Seagen Inc. | M Exercise | 2020-11-19 | 2020-11-23 | 7,871 | $19.02 | $149.7K | 52,719 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2020-11-19 | 2020-11-23 | 7,871 | $173.25 | $1.36M | 44,848 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2020-11-19 | 2020-11-23 | 7,129 | $174.20 | $1.24M | 44,848 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | M Exercise deriv | 2020-11-18 | 2020-11-20 | 60,000 | $1.64 | $98.4K | 66,050 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | S Sale | 2020-11-18 | 2020-11-19 | 50,000 | $2.39 | $119.5K | 95,337 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | M Exercise | 2020-11-18 | 2020-11-20 | 60,000 | $1.64 | $98.4K | 155,337 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | S Sale | 2020-11-17 | 2020-11-19 | 100,000 | $2.40 | $240.0K | 145,337 | SEC↗ |
| SGEN Seagen Inc. | S Sale | 2020-11-05 | 2020-11-06 | 4,500 | $180.60 | $812.7K | 44,848 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2020-09-14 | 2020-09-16 | 35,208 | — | $0 | 35,208 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2020-08-19 | 2020-08-24 | 118,671 | $3.63 | $430.8K | 118,671 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2020-08-19 | 2020-08-24 | 25,826 | — | $0 | 245,337 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2020-06-11 | 2020-06-29 | 7,800 | — | $0 | 7,800 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award | 2020-06-11 | 2020-06-29 | 1,750 | — | $0 | 3,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2020-05-15 | 2020-05-19 | 3,171 | — | $0 | 3,171 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2020-05-15 | 2020-05-19 | 1,335 | — | $0 | 49,348 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2019-10-01 | 2019-10-03 | 2,500 | — | $0 | 15,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2019-10-01 | 2019-10-03 | 2,500 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2019-10-01 | 2019-10-03 | 2,500 | $84.85 | $212.1K | 48,013 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2019-10-01 | 2019-10-03 | 2,500 | $12.76 | $31.9K | 50,513 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2019-10-01 | 2019-10-03 | 2,500 | $85.33 | $213.3K | 48,013 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2019-10-01 | 2019-10-03 | 2,500 | $19.02 | $47.5K | 50,513 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2019-07-17 | 2019-07-19 | 5,000 | — | $0 | 2,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2019-07-17 | 2019-07-19 | 5,000 | $75.00 | $375.0K | 48,013 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2019-07-17 | 2019-07-19 | 5,000 | $12.76 | $63.8K | 53,013 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2019-06-20 | 2019-06-24 | 126,050 | $3.00 | $378.1K | 126,050 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2019-05-23 | 2019-05-23 | 7,800 | — | $0 | 7,800 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award | 2019-05-23 | 2019-05-23 | 1,750 | — | $0 | 1,750 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2019-05-20 | 2019-05-22 | 7,038 | — | $0 | 7,038 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2019-05-20 | 2019-05-22 | 2,963 | — | $0 | 48,013 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2019-04-01 | 2019-04-03 | 5,000 | — | $0 | 7,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2019-04-01 | 2019-04-03 | 5,000 | $12.76 | $63.8K | 50,050 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2019-04-01 | 2019-04-03 | 4,794 | $73.38 | $351.8K | 45,256 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2019-04-01 | 2019-04-03 | 206 | $74.01 | $15.2K | 45,050 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2019-01-08 | 2019-01-10 | 5,000 | — | $0 | 12,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2019-01-08 | 2019-01-10 | 5,000 | $65.04 | $325.2K | 45,050 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2019-01-08 | 2019-01-10 | 5,000 | $12.76 | $63.8K | 50,050 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2018-09-12 | 2018-09-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2018-07-16 | 2018-07-18 | 455 | $70.19 | $31.9K | 10,235 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2018-07-05 | 2018-07-05 | 280 | $68.28 | $19.1K | 10,690 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2018-07-02 | 2018-07-05 | 22,772 | — | $0 | 22,772 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2018-06-08 | 2018-06-12 | 54,348 | $2.76 | $150.0K | 219,511 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2018-05-18 | 2018-05-22 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2018-05-18 | 2018-05-22 | 3,700 | — | $0 | 45,050 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2018-02-21 | 2018-02-22 | 1,952 | $85.56 | $167.0K | 10,970 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2018-02-20 | 2018-02-22 | 1,070 | $86.03 | $92.1K | 12,922 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2018-01-23 | 2018-01-25 | 12,128 | — | $0 | 12,128 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2018-01-05 | 2018-01-09 | 6,760 | — | $0 | 11,735 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2018-01-05 | 2018-01-09 | 6,760 | $83.83 | $566.7K | 20,752 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2018-01-05 | 2018-01-09 | 6,760 | $98.87 | $668.4K | 13,992 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-11-02 | 2017-11-03 | 3,915 | $105.63 | $413.5K | 13,992 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2017-11-01 | 2017-11-03 | 3,913 | $107.96 | $422.4K | 17,907 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2017-09-13 | 2017-09-15 | 712 | $123.15 | $87.7K | 21,820 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-07-05 | 2017-07-07 | 11,349 | — | $0 | 11,349 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-07-05 | 2017-07-07 | 779 | — | $0 | 779 | SEC↗ |
| INCY INCYTE CORP | A Award | 2017-07-05 | 2017-07-07 | 3,517 | — | $0 | 22,532 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-06-30 | 2017-07-05 | 599 | — | $0 | 3,591 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-06-30 | 2017-07-05 | 599 | $73.21 | $43.9K | 19,614 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-06-30 | 2017-07-05 | 599 | $129.74 | $77.7K | 19,015 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-06-12 | 2017-06-14 | 16,756 | — | $0 | 4,190 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-06-12 | 2017-06-14 | 16,756 | $116.60 | $1.95M | 19,015 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-06-12 | 2017-06-14 | 16,756 | $73.21 | $1.23M | 35,771 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2017-06-09 | 2017-06-12 | 60,729 | $2.47 | $150.0K | 165,163 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2017-05-19 | 2017-05-23 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2017-05-19 | 2017-05-23 | 3,700 | — | $0 | 41,350 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-04-28 | 2017-05-02 | 1,389 | — | $0 | 9,725 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-04-28 | 2017-05-02 | 1,389 | $67.06 | $93.1K | 20,404 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-04-28 | 2017-05-02 | 1,389 | $124.26 | $172.6K | 19,015 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-04-10 | 2017-04-11 | 1,739 | — | $0 | 2,734 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-04-10 | 2017-04-11 | 39,789 | — | $0 | 11,114 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-04-10 | 2017-04-11 | 1,739 | $138.00 | $240.0K | 58,804 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-04-10 | 2017-04-11 | 1,739 | $67.06 | $116.6K | 20,754 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-04-10 | 2017-04-11 | 39,789 | $138.00 | $5.49M | 19,015 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-04-10 | 2017-04-11 | 39,789 | $67.06 | $2.67M | 60,543 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-01-17 | 2017-01-19 | 19,091 | — | $0 | 19,091 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2016-09-06 | 2016-09-08 | 10,000 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2016-09-06 | 2016-09-08 | 10,000 | $10.20 | $102.0K | 37,650 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-07-15 | 2016-07-19 | 596 | — | $0 | 596 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-07-15 | 2016-07-19 | 18,495 | — | $0 | 18,495 | SEC↗ |
| INCY INCYTE CORP | A Award | 2016-07-15 | 2016-07-19 | 5,555 | — | $0 | 19,015 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2016-06-02 | 2016-06-03 | 71,023 | $3.52 | $250.0K | 104,434 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2016-05-20 | 2016-05-24 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2016-05-20 | 2016-05-24 | 3,700 | — | $0 | 27,650 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-01-07 | 2016-01-08 | 1,108 | — | $0 | 1,108 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-01-07 | 2016-01-08 | 17,676 | — | $0 | 17,676 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-01-07 | 2016-01-08 | 2,995 | — | $0 | 2,995 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-01-07 | 2016-01-08 | 1,044 | — | $0 | 1,044 | SEC↗ |
| INCY INCYTE CORP | A Award | 2016-01-07 | 2016-01-08 | 2,610 | — | $0 | 13,460 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2015-11-05 | 2015-11-05 | 10,000 | $43.57 | $435.7K | 23,950 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2015-05-28 | 2015-05-29 | 22,059 | $6.80 | $150.0K | 33,411 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2015-05-15 | 2015-05-19 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2015-05-15 | 2015-05-19 | 3,700 | — | $0 | 33,950 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2015-04-10 | 2015-04-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award | 2015-04-10 | 2015-04-14 | 1,700 | — | $0 | 1,700 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2015-04-08 | 2015-04-10 | 5,000 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2015-04-08 | 2015-04-10 | 5,000 | $8.38 | $41.9K | 30,250 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 20,946 | — | $0 | 20,946 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 599 | — | $0 | 599 | SEC↗ |
| INCY INCYTE CORP | A Award | 2015-01-08 | 2015-01-09 | 3,022 | — | $0 | 10,850 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-10-31 | 2014-11-04 | 50,903 | — | $0 | 50,903 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-10-31 | 2014-11-04 | 4,473 | — | $0 | 4,473 | SEC↗ |
| INCY INCYTE CORP | A Award | 2014-10-31 | 2014-11-04 | 7,828 | — | $0 | 7,828 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2014-06-11 | 2014-06-13 | 13,500 | — | $0 | 13,500 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2014-05-28 | 2014-05-30 | 5,371 | $9.31 | $50.0K | 11,352 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2014-05-16 | 2014-05-20 | 8,750 | $34.25 | $299.7K | 8,750 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2014-05-16 | 2014-05-20 | 3,500 | — | $0 | 25,250 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2014-03-06 | 2014-03-10 | 5,981 | $8.36 | $50.0K | 5,981 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2013-09-03 | 2013-09-05 | 10,000 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2013-09-03 | 2013-09-05 | 10,000 | $10.08 | $100.8K | 32,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2013-09-03 | 2013-09-05 | 10,000 | $42.48 | $424.8K | 22,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2013-05-17 | 2013-05-21 | 8,750 | $36.70 | $321.1K | 8,750 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2013-05-17 | 2013-05-21 | 3,500 | — | $0 | 22,000 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2013-04-15 | 2013-05-01 | 9,800 | — | $0 | 9,800 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2013-02-26 | 2013-02-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2013-02-26 | 2013-02-27 | 5,000 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2013-02-26 | 2013-02-27 | 5,000 | $5.00 | $25.0K | 13,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2013-02-26 | 2013-02-27 | 5,000 | $8.38 | $41.9K | 18,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2013-02-25 | 2013-02-27 | 10,000 | $27.17 | $271.7K | 8,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2012-08-10 | 2012-08-14 | 7,500 | — | $0 | 5,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2012-08-10 | 2012-08-14 | 7,500 | $5.00 | $37.5K | 19,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2012-06-05 | 2012-06-06 | 8,000 | $19.75 | $158.0K | 11,500 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2012-05-18 | 2012-05-22 | 17,500 | $20.06 | $351.1K | 17,500 | SEC↗ |